In addition, the comparison of 5-year survival rates across all stages of CRC revealed that cases with positive CD44v9 mRNA expression and high CEA had worse 5-year DSS compared with the other cases (43.1% vs. 81.5%, p < 0.001; Figure 7). The gene discussed is CEACAM5; the disease is colorectal carcinoma.